Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

This led them to the conclusion that antibiotics, antivirals and anti-inflammatory drugs were all associated with reduced ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.